ROSWELL PARK CANCER INSTITUTE will collaborate with GenomOncology to develop an informatics solution that enables the association of next-generation sequencing results with knowledge resources to define actionable mutations.
As NCI paylines drop to 4%, cancer centers are tapping into their institutional funds to provide “bridge funding,” typically in $50,000 to $100,000 increments, to enable investigators to keep their labs open until better times return—next year God willing.
